Healthcare Plans: UnitedHealth Group Incorporated owns the largest revenue base; Clover Health Investments, Corp. has the fastest current growth.
The industry itself · before any single company
How has Healthcare Plans moved against S&P 500?
The line below covers 5.2 years. Over the most recent two of them this industry is 1% ahead of S&P 500. Earnings across its companies fell 17% on average over the last four reported quarters. It has been ahead of S&P 500 on a rolling three-month view for 14 weeks running.
LEADER · ahead 14w⚠Moving with the index7 of 11 companies ahead of S&P 500 by 5% or more over three months
Healthcare Plans, equal-weighted, based at 200S&P 500, same base, same starttrailing 12-month earnings per share risingfalling
Strength anatomyBroad but lateHow much of the industry is participating, how recently, and whether the movers score well.
Together7 of 11 stocks moving
Fresh0 crossed in the last 4 weeks
Backed by scoresmovers score +7 vs the industry average
Down the cap ladder — bar is now, tick is four weeks ago
Large2/3−1
Mid2/4−1
Small3/4−1
Participation is not spreading downward this month; the larger companies are still carrying most of it.
Both lines start at 200 in the same week, so the distance between them is the whole story: the industry line is an equal-weighted index of its 11 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the industry taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Sector relative strength · before individual stocks
Is Healthcare Plans outperforming S&P 500?
Healthcare Plans has outperformed S&P 500 by 46.9% over the last 52 weeks. Over 13 weeks the gap is a lead of 26.5%. 9 of 11 covered companies currently beat the S&P 500 on Mansfield relative strength, so leadership inside the sector is selective. Oscar Health, Inc. is the strongest against the sector itself at +26.9%.
+26.5%Sector vs S&P 500 · 13 weeks
+46.9%Sector vs S&P 500 · 52 weeks
9/11Stocks leading S&P 500
4/11Stocks leading sector
Sector metric: — as of latest available · unclassified · direction unavailable.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Healthcare Plans has outperformed S&P 500 by 46.9% over 52 weeks and 26.5% over 13 weeks. 9 of 11 covered companies beat the S&P 500 on Mansfield relative strength, while 4 of 11 beat the sector itself. UnitedHealth Group Incorporated leads with revenue of $450,129 million, based on 9 of 11 comparable companies through Jun 2026.
Is the Healthcare Plans sector outperforming S&P 500?
Healthcare Plans has outperformed S&P 500 by 46.9% over 52 weeks and 26.5% over 13 weeks. 9 of 11 covered companies beat the S&P 500 on Mansfield relative strength, while 4 of 11 beat the sector itself.
Which Healthcare Plans company is largest by revenue?
UnitedHealth Group Incorporated leads with revenue of $450,129 million, based on 9 of 11 comparable companies through Jun 2026.
Which Healthcare Plans company is growing fastest?
Clover Health Investments, Corp. has the fastest current revenue growth at 48.9%, across 9 of 11 comparable companies.
Which Healthcare Plans company has the strongest 4-Factor Sector Score?
Progyny, Inc. ranks first at 70.6/100 with 82% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Healthcare Plans company reports the most CAPEX?
CVS Health Corporation reports the largest latest CAPEX at $849 million, with 11 of 11 companies comparable.
Which Healthcare Plans company has the least gross debt?
Clover Health Investments, Corp. has the lowest comparable gross debt at $0 million. CVS Health Corporation has the highest at $78,345 million.
Which Healthcare Plans company has the lowest comparable PEG?
The Cigna Group has the lowest comparable Guarded PEG at 0.37, among 4 of 11 companies that pass the metric’s comparability rules.
How much history does this Healthcare Plans comparison include?
The page compares up to 20 reported quarters per company for fundamentals, CAPEX, debt and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Companies
11
complete canonical membership
Combined market value
$798.8B
UnitedHealth Group Incorporated
Revenue growing
9/9
positive TTM year-on-year growth
Beating S&P 500
9/11
positive Mansfield relative strength
Global company selection
00 · research priority, made explicit
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
Progyny, Inc. has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 82% evidence confidence.
Centene Corporation has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.
Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11.4/35Growth & earnings
Revenue — · PAT — · OPM change -3.1 pp
45% evidence
6.6/25Capital efficiency
ROCE 1.7% · debt/equity 0.95×
80% evidence
9.2/20Valuation
P/E 39.4× · PEG —
15% evidence
6.5/20Relative strength
RS sector -14.7% · RS bench 7.6% · 1Y 29.1%
100% evidence
01 · compare level, then change
Revenue Scale & Growth Durability
UnitedHealth Group Incorporated has the highest Revenue among the 11 Healthcare Plans companies compared here, at $450,129 million. CVS Health Corporation is next at $407,905 million. Clover Health Investments, Corp. has the highest Revenue growth at 48.9%, so level and change sit with different companies. 9 of 11 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: UnitedHealth Group Incorporated is the scale leader at $450,129 million, 10.4% ahead of CVS Health Corporation. Clover Health Investments, Corp.'s growth is 48.9% from a $2,212 million base, with 19 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
LeaderUnitedHealth Group Incorporated · $450,129 million
Gap10.4% versus #2 · CVS Health Corporation
Persistence8/8 recent comparable periods
Coverage9/11 companies · 210 observations
Investor read: UnitedHealth Group Incorporated is the scale benchmark; Clover Health Investments, Corp. is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: UnitedHealth Group Incorporated's growth falls below Clover Health Investments, Corp.'s for two consecutive comparable reports while operating margin also compresses.
Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
1UnitedHealth Group Incorporated UNH$450.1B
2CVS Health Corporation CVS$407.9B
3The Cigna Group CI$277.9B
4Centene Corporation CNC$198.1B
5Humana Inc. HUM$137.2B
Revenue growthfastest growers
1Clover Health Investments, Corp. CLOV49%
2Alignment Healthcare, Inc. ALHC42%
3Oscar Health, Inc. OSCR32%
4Centene Corporation CNC17%
5Humana Inc. HUM14%
Revenue · company comparison
9/11 level · 9/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Oscar Health, Inc. has the highest OPM among the 11 Healthcare Plans companies compared here, at 15.2%. Progyny, Inc. is next at 10.8%. The same company also holds the highest Margin change, at +5.4 percentage points. 11 of 11 companies report a comparable reading, the latest through Mar 2026. Its OPM series carries 19 reported observations across the 20-quarter window.
What the numbers say: Oscar Health, Inc. leads both opm at 15.2% and margin change at +5.4 percentage points.
LeaderOscar Health, Inc. · 15.2%
Gap40.7% versus #2 · Progyny, Inc.
Persistence5/8 recent comparable periods
Coverage11/11 companies · 210 observations
Investor read: Oscar Health, Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
1Oscar Health, Inc. OSCR15%
2Progyny, Inc. PGNY11%
3UnitedHealth Group Incorporated UNH7.1%
4CVS Health Corporation CVS4.7%
5Humana Inc. HUM4.4%
Margin changefastest expanders
1Oscar Health, Inc. OSCR+5.4 pp
2Clover Health Investments, Corp. CLOV+3.9 pp
3Progyny, Inc. PGNY+3.3 pp
4UnitedHealth Group Incorporated UNH+2.5 pp
5Alignment Healthcare, Inc. ALHC+1.9 pp
Operating margin · company comparison
11/11 level · 11/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
UnitedHealth Group Incorporated has the highest Net profit among the 11 Healthcare Plans companies compared here, at $14,912 million. The Cigna Group is next at $6,740 million. Progyny, Inc. has the highest Profit growth at 28.9%, so level and change sit with different companies. 9 of 11 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: UnitedHealth Group Incorporated leads with $14,912 million of TTM profit, 121.2% above The Cigna Group. Progyny, Inc. shows 28.9% growth from a $67 million profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
LeaderUnitedHealth Group Incorporated · $14,912 million
Gap121.2% versus #2 · The Cigna Group
Persistence4/8 recent comparable periods
Coverage9/11 companies · 210 observations
Investor read: UnitedHealth Group Incorporated sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
1UnitedHealth Group Incorporated UNH$14.9B
2The Cigna Group CI$6.7B
3CVS Health Corporation CVS$2.9B
4Humana Inc. HUM$1.1B
5Progyny, Inc. PGNY$67M
Profit growthfastest growers
1Progyny, Inc. PGNY29%
2The Cigna Group CI25%
3UnitedHealth Group Incorporated UNH-33%
4Humana Inc. HUM-33%
5CVS Health Corporation CVS-45%
Net profit · company comparison
9/11 level · 7/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
CVS Health Corporation has the highest CAPEX among the 11 Healthcare Plans companies compared here, at $849 million. UnitedHealth Group Incorporated is next at $799 million. Progyny, Inc. has the highest CAPEX intensity at 1.8%, so level and change sit with different companies. 11 of 11 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: CVS Health Corporation reports $849 million of CAPEX; Progyny, Inc. has the highest covered intensity at 1.8%. Coverage is only 11 of 11 companies and 209 reported observations, so this is partial evidence—not a complete sector rank.
LeaderCVS Health Corporation · $849 million
Gap6.3% versus #2 · UnitedHealth Group Incorporated
Persistence8/8 recent comparable periods
Coverage11/11 companies · 209 observations
Investor read: Use the CAPEX rank as a diligence queue. Verify commissioning, utilization, cash conversion and post-investment ROCE before treating spend as value creation.
This conclusion weakens if: CAPEX rises without higher utilization, operating cash flow or incremental returns.
CAPEX is cash spent on property, plant, equipment and other reported capital assets. CAPEX intensity divides that spend by revenue; high intensity is a reinvestment signal, not proof that the reinvestment will earn attractive returns.
CAPEXlargest spenders
1CVS Health Corporation CVS$849M
2UnitedHealth Group Incorporated UNH$799M
3Elevance Health, Inc. ELV$287M
4The Cigna Group CI$267M
5Centene Corporation CNC$200M
CAPEX intensityhighest reinvestment intensity
1Progyny, Inc. PGNY1.8%
2CVS Health Corporation CVS0.8%
3UnitedHealth Group Incorporated UNH0.7%
4Alignment Healthcare, Inc. ALHC0.6%
5Elevance Health, Inc. ELV0.5%
Capital expenditure · company comparison
11/11 level · 11/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Capacity base is net fixed assets plus capital work in progress, straight off the reported balance sheet. It is not cash spent, so it answers a narrower question than CAPEX — but it is reported for companies whose cash-flow CAPEX is not published, which is why it leads here. Missing years remain blank; annual values are never relabelled as quarters.
Full annual capacity base, operating cash flow, CAPEX and free cash flow history
Capacity base · net fixed assets + CWIP · fiscal-year history
Clover Health Investments, Corp. has the lowest Gross debt among the 11 Healthcare Plans companies compared here, at $0 million. Progyny, Inc. is next at $23 million. Centene Corporation has the lowest Net debt at $7,370 million net cash, so level and change sit with different companies. 9 of 11 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Centene Corporation has the clearest covered balance-sheet capacity with $7,370 million net cash and gross debt of $16,371 million. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.
LeaderClover Health Investments, Corp. · $0 million
Gap100% versus #2 · Progyny, Inc.
Persistence8/8 recent comparable periods
Coverage9/11 companies · 173 observations
Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.
This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.
Gross debt shows contractual borrowings. Net debt subtracts reported cash; a negative value means net cash. Lower debt can create capacity, but should be read against the scale and capital intensity of the business.
Gross debtlowest gross debt
1Clover Health Investments, Corp. CLOV$0M
2Progyny, Inc. PGNY$23M
3Alignment Healthcare, Inc. ALHC$330M
4Oscar Health, Inc. OSCR$431M
5Molina Healthcare, Inc. MOH$4.0B
Net debtlowest net debt
1Centene Corporation CNC$-7.4B
2Elevance Health, Inc. ELV$-6.5B
3Oscar Health, Inc. OSCR$-6.4B
4Molina Healthcare, Inc. MOH$-5.0B
5Alignment Healthcare, Inc. ALHC$-396M
Debt and balance-sheet capacity · company comparison
9/11 level · 9/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Oscar Health, Inc. has the highest ROCE among the 11 Healthcare Plans companies compared here, at 36.6%. Clover Health Investments, Corp. is next at 7.5%. The same company also holds the highest ROCE change, at +17.4 percentage points. 11 of 11 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Oscar Health, Inc. leads ROCE at 36.6%, 29.1 percentage points above Clover Health Investments, Corp.. Oscar Health, Inc. has the strongest latest improvement at +17.4 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
LeaderOscar Health, Inc. · 36.6%
Gap388% versus #2 · Clover Health Investments, Corp.
Persistence5/8 recent comparable periods
Coverage11/11 companies · 212 observations
Investor read: Oscar Health, Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
1Oscar Health, Inc. OSCR37%
2Clover Health Investments, Corp. CLOV7.5%
3Progyny, Inc. PGNY7.4%
4Centene Corporation CNC4.1%
5Humana Inc. HUM3.3%
ROCE changefastest improvers
1Oscar Health, Inc. OSCR+17.4 pp
2Clover Health Investments, Corp. CLOV+7.9 pp
3Alignment Healthcare, Inc. ALHC+4.7 pp
4Progyny, Inc. PGNY+2.9 pp
5Centene Corporation CNC+1.0 pp
Return on capital · company comparison
11/11 level · 11/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
The Cigna Group has the lowest Guarded PEG among the 11 Healthcare Plans companies compared here, at 0.37×. Progyny, Inc. is next at 0.63×. The same company also holds the lowest P/E, at 11.3×. 4 of 11 companies report a comparable reading, the latest through Mar 2026. Its Guarded PEG series carries 5 reported observations across the 20-quarter window.
What the numbers say: The Cigna Group has the lowest comparable Guarded PEG at 0.37×, 41.3% below Progyny, Inc.. Only 4 of 11 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
LeaderThe Cigna Group · 0.37×
Gap41.3% versus #2 · Progyny, Inc.
Persistence0/8 recent comparable periods
Coverage4/11 companies · 41 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data sources reconciled. A missing PEG is more honest than a low-base fiction.
Guarded PEGlowest PEG
1The Cigna Group CI0.4
2Progyny, Inc. PGNY0.6
3UnitedHealth Group Incorporated UNH0.7
4Humana Inc. HUM2.2
P/Elowest P/E
1The Cigna Group CI11.3
2Centene Corporation CNC13.4
3Elevance Health, Inc. ELV17.2
4Humana Inc. HUM18.5
5Progyny, Inc. PGNY22.1
Valuation · company comparison
4/11 level · 10/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Oscar Health, Inc. has the lowest EV/EBITDA among the 11 Healthcare Plans companies compared here, at 3.19×. Humana Inc. is next at 6.43×. Centene Corporation has the lowest P/BV at 0.75×, so level and change sit with different companies. 11 of 11 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Oscar Health, Inc. leads ev/ebitda at 3.19×; Centene Corporation leads p/bv at 0.75×.
LeaderOscar Health, Inc. · 3.19×
Gap50.4% versus #2 · Humana Inc.
Persistence0/8 recent comparable periods
Coverage11/11 companies · 176 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.
EV/EBITDA includes debt in enterprise value and is useful across different capital structures. P/BV prices the company against its own book. Both are market multiples on reported figures, not intrinsic-value estimates and not forecasts.
EV/EBITDAlowest EV/EBITDA
1Oscar Health, Inc. OSCR3.2
2Humana Inc. HUM6.4
3The Cigna Group CI7.6
4Centene Corporation CNC8.6
5Progyny, Inc. PGNY11.1
P/BVlowest P/BV
1Centene Corporation CNC0.8
2Humana Inc. HUM1.1
3CVS Health Corporation CVS1.2
4The Cigna Group CI1.7
5Elevance Health, Inc. ELV1.9
Enterprise and book valuation · company comparison
11/11 level · 11/11 change
Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.
All-company data · latest reported quarter
Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Centene Corporation has the strongest one-year price move in Healthcare Plans at +146.7%. Oscar Health, Inc. leads on Mansfield relative strength against the S&P 500 at +57.3%. 9 of 11 covered companies are above zero on that measure. Every line covers 314 weekly closes through 2026-07-28.
Every price line is indexed to 100 over the chosen window. Mansfield relative strength compares a price ratio with its own 52-week average; zero separates leadership from lagging.
Price and relative strength
Price is rebased to 100 inside the selected window. Pair ratio rebases each selected company against one chosen denominator.
Before the conclusion · check the blind spots
What can make this comparison misleading?
This Healthcare Plans comparison names 4 specific ways its own evidence can mislead, all listed below. All 11 companies here report on comparable dates, so no rank carries a stale marker. A high growth rate can still be a low-base artefact.
Keep these limits visible
A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
10 · the complete set
Which companies are included?
All 11 companies in the canonical Healthcare Plans membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. The charts above default to a selective view; this register is the complete set, with each company's own latest reporting date beside it.
AHEAD means the company is beating the index by 5% or more over three months. LAGGING, FUNDAMENTALS UP means it is 20% or more behind over a year while its trailing twelve-month earnings grew 20% or more. Both rules are fixed and applied the same way in every sector.
This comparison is built from the reported filings of 11 Healthcare Plans companies, normalized to a common $ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-28. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-07-28 · weekly price and relative-strength history
Derived metricsGrowth, changes, CAPEX intensity, net debt, guarded PEG and P/BV÷ROE are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
These 18 answers restate the Healthcare Plans comparison above in question form. Every one is computed from the same 11 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-28. Nothing here is estimated, and none of it is a recommendation.
Which Healthcare Plans company is the biggest?
UnitedHealth Group Incorporated is the largest, with trailing-twelve-month revenue of $450,129 million, ahead of CVS Health Corporation at $407,905 million. That covers 9 of 11 companies with comparable reporting through Jun 2026.
Which Healthcare Plans company is growing fastest?
Clover Health Investments, Corp. has the fastest revenue growth at 48.9% year on year, across 9 of 11 comparable companies. Fast growth off a small base is not the same as proven scale — check whether the rate holds across several quarters on the chart above before treating it as a trend.
Which Healthcare Plans company has the best profit margins?
Oscar Health, Inc. has the highest operating margin at 15.2%, from 11 of 11 comparable companies. Oscar Health, Inc. shows the biggest recent improvement, at +5.4 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Healthcare Plans company makes the most profit?
UnitedHealth Group Incorporated earns the most, at $14,912 million of trailing-twelve-month net profit, from 9 of 11 comparable companies. Progyny, Inc. has the fastest profit growth at 28.9%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Healthcare Plans company earns the highest return on capital?
Oscar Health, Inc. leads on return on capital employed at 36.6%, across 11 of 11 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Healthcare Plans stock is the cheapest?
On guarded PEG — where a LOWER number is cheaper — The Cigna Group screens cheapest at 0.37×. Only 4 of 11 companies pass the comparability guard, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Which Healthcare Plans company has the strongest balance sheet?
Clover Health Investments, Corp. carries the lowest comparable gross debt at $0 million, from 9 of 11 companies. Absolute rupee debt alone does not settle it, because company scale differs — net debt and debt-to-equity in the chart above carry more information, and a very low-debt balance sheet can also mean under-investment.
Which Healthcare Plans company is investing most in new capacity?
CVS Health Corporation reports the largest capital spending at $849 million, across 11 of 11 companies. Spending consumes cash before it earns anything, so treat the ranking as a diligence queue: check commissioning, utilisation and the return earned on the completed assets before reading spend as value creation.
Is the Healthcare Plans sector beating the market?
Healthcare Plans has outperformed S&P 500 by 46.9% over the last 52 weeks and 26.5% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 9 of 11 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Healthcare Plans stock has the strongest price momentum?
Oscar Health, Inc. has the strongest relative strength against S&P 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Healthcare Plans company scores highest for research priority?
Progyny, Inc. scores 70.6 out of 100 with 82% evidence confidence, from 24.6 points on growth and earnings, 17 on capital efficiency, 15.2 on valuation and 13.8 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Healthcare Plans companies does this comparison cover, and over what period?
It compares 11 listed companies over up to 20 reported quarters of fundamentals and 5 fiscal years of capital allocation, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Healthcare Plans sector?
The 11 Healthcare Plans companies on this page carry $798,842 million of combined market value. UnitedHealth Group Incorporated is the largest at $389,403 million, about 49% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-07-28.
What is the Healthcare Plans sector's P/E ratio?
The median price-to-earnings ratio across the 11 Healthcare Plans companies on this page is 26.7×, measured on the 10 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-07-28.
How is the Healthcare Plans sector performing?
9 of the 11 covered Healthcare Plans companies are beating S&P 500 on Mansfield relative strength. The sector itself is 46.9% ahead of S&P 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-07-28.
How many Healthcare Plans stocks are listed in the US?
This comparison covers 11 listed Healthcare Plans companies in the US, each above the size floor the site applies. The full ranked list is on this page, with reported fundamentals through Jun 2026. Membership is the full industry list — nothing is dropped for having thin data.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.